Adalimumab and Adalimumab Ab ADALIMUMAB

Synonyms

Humira(TM)
Anti-TNF-? Drug

Allscripts (AEHR) Order Name

Adalimumab Drug + Antibody

Sunrise Clinical Manager (SCM) Order Name

Adalimumab Drug + Antibody

EPIC Order Name

Adalimumab and Anti-Adalimumab Antibody (DoseAssure)

Clinical Info

Monitor antiadalimumab therapy for individuals with Crohn's disease, inflammatory bowel disease, ulcerative colitis, rheumatoid arthritis, or other autoimmune conditions. This test provides adalimumab drug concentration levels as well as the level of antiadalimumab antibodies.

Specimen Type

Blood

Container

Gold Top Tube

Collection Instructions

Container/Tube: Red top or Gold top tube
Specimen: 2ml serum (1 mL min)
Transport Temperature: Frozen

Transport Instructions

Frozen

Specimen Stability

7 Days Room Temperature
7 Days Refrigerated
308 Days Frozen

Methodology

Electrochemiluminescence immunoassay (ECLIA)

Days Performed

TAT: 7-10 Days

Performing Laboratory

LabCorp of America

CPT

80145
82397
LOINC Code: 99781-7

PDM

5903888

Result Interpretation

Adalimumab Drug Level
• Quantitation limit: <0.6 μg/mL

• Results ≥0.6 μg/mL indicate detection of adalimumab.

In the presence of antiadalimumab antibody, the adalimumab drug level reflects the antibody-unbound fraction of adalimumab concentration in serum.
Antiadalimumab Antibody
 
• Quantitation limit: <25 ng/mL

• Results ≥25 ng/mL indicate detection of adalimumab antibody.

Forms

edit